Developer docs
API playgroundTry for free, no card

Search company profiles

Pulsion Medical Systems

Full company profile

uuid0029sx8

Namestring
Pulsion Medical Systems
Legal namestring
Pulsion Medical Systems SE
Websiteurl
http://www.pulsion.com
Company typeenum
Public
Founded yearint
1904
Descriptiontext

Pulsion Medical Systems SE is a European medical technology company (Societas Europaea) headquartered in Aschheim-Dornach, Germany, specializing in minimally invasive physiological monitoring systems used in intensive care units (ICUs) and patient rooms. Its products are designed to support hemodynamic and cardiovascular monitoring in critical care and cardiovascular procedure settings, with related offerings in cardiovascular interventions and operating-room integration that align with the broader Getinge acute-care portfolio. The company historically operated as a publicly listed entity with its own administrative board and published annual financial reports for 2020-2024.

Pulsion is a wholly-owned subsidiary of Getinge AB (headquartered in Gothenburg, Sweden), with MAQUET Medical Systems AG — a Getinge group company — serving as the principal shareholder (Hauptaktionärin). Through Getinge's global commercial and service infrastructure, Pulsion's products reach customers across more than 24 countries spanning EMEA, the Americas, Asia, and Oceania. The company maintains dedicated investor relations communications separate from Getinge's main investor page, including [email protected] as a contact channel.

On October 17, 2025, Pulsion convened an extraordinary shareholders' meeting to approve the transfer of remaining shares to Getinge, effectively completing the delisting and taking Pulsion fully private. This delisting is a corporate restructuring event, not an operating change, and consolidates Pulsion's role as an integrated product line within the Getinge group. The company's investor relations page (the primary source of available data) contains administrative and governance information rather than product-level detail.

Short descriptiontext

Pulsion Medical Systems SE is a medical technology company that develops and sells minimally invasive physiological monitoring systems for ICUs and patient rooms. It operates as a wholly-owned subsidiary of Getinge AB and was being taken private in 2025.

Operating statusenum
Acquired
Ownership categoryenum
akta.pro rankint
HeadquartersGothenburg, Sweden
HQ citystring
Gothenburg
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
physiological monitoring systems, ICU patient monitoring, minimally invasive monitoring, critical care monitoring, hemodynamic monitoring devices
Industry2 codes
1Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT)
CodeHLAHAFAIPrimaryYes
2Critical Care / ICU Pulmonology (Intensivist Services)
CodeHLAKANAHPrimaryNo
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Patient Monitoring Systems
Social media profiles1 record
Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Pulsion Medical Systems SE designs, develops, manufactures, and sells minimally invasive physiological monitoring systems used in intensive care units (ICUs) and patient rooms. The company focuses on medical technology solutions for intensive care and cardiovascular procedures, operating as a wholly-owned subsidiary of Getinge AB with MAQUET Medical Systems AG serving as the majority shareholder.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Pulsion Medical Systems SE is a subsidiary of Getinge, operating as a medical technology company. The source data contains only investor relations information (shareholder meeting notices, financial reports from 2020-2024, articles of association, and administrative board composition) with no product or service listings.

Partnership1 partner
1Getinge AB
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pulsion Medical Systems SE is a wholly-owned subsidiary of Getinge AB. MAQUET Medical Systems AG, a Getinge group company, is the majority shareholder. The company is undergoing delisting, with an extraordinary shareholders' meeting held on October 17, 2025 to approve the transfer of shares to Getinge.

getinge.com
Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Market position
Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pulsion Medical Systems

Patient Monitoring Systemspulsion.com

Pulsion Medical Systems SE is a medical technology company that develops and sells minimally invasive physiological monitoring systems for ICUs and patient rooms. It operates as a wholly-owned subsidiary of Getinge AB and was being taken private in 2025.

What Pulsion Medical Systems does

Pulsion Medical Systems SE is a European medical technology company (Societas Europaea) headquartered in Aschheim-Dornach, Germany, specializing in minimally invasive physiological monitoring systems used in intensive care units (ICUs) and patient rooms. Its products are designed to support hemodynamic and cardiovascular monitoring in critical care and cardiovascular procedure settings, with related offerings in cardiovascular interventions and operating-room integration that align with the broader Getinge acute-care portfolio. The company historically operated as a publicly listed entity with its own administrative board and published annual financial reports for 2020-2024.

Pulsion is a wholly-owned subsidiary of Getinge AB (headquartered in Gothenburg, Sweden), with MAQUET Medical Systems AG — a Getinge group company — serving as the principal shareholder (Hauptaktionärin). Through Getinge's global commercial and service infrastructure, Pulsion's products reach customers across more than 24 countries spanning EMEA, the Americas, Asia, and Oceania. The company maintains dedicated investor relations communications separate from Getinge's main investor page, including [email protected] as a contact channel.

On October 17, 2025, Pulsion convened an extraordinary shareholders' meeting to approve the transfer of remaining shares to Getinge, effectively completing the delisting and taking Pulsion fully private. This delisting is a corporate restructuring event, not an operating change, and consolidates Pulsion's role as an integrated product line within the Getinge group. The company's investor relations page (the primary source of available data) contains administrative and governance information rather than product-level detail.

Pulsion Medical Systems firmographics

Firmographics
Name
Pulsion Medical Systems
Legal name
Pulsion Medical Systems SE
Website
http://www.pulsion.com
Company type
Public
Founded year
1904
Operating status
Acquired
Short description
Pulsion Medical Systems SE is a medical technology company that develops and sells minimally invasive physiological monitoring systems for ICUs and patient rooms. It operates as a wholly-owned subsidiary of Getinge AB and was being taken private in 2025.
Ownership category
akta.pro rank

Pulsion Medical Systems industry classification

Industry
Product category
Patient Monitoring Systems
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)
akta.pro secondary industry
Critical Care / ICU Pulmonology (Intensivist Services) (HLAKANAH)

Keywords

  • Physiological monitoring systems
  • ICU patient monitoring
  • Minimally invasive monitoring
  • Critical care monitoring
  • Hemodynamic monitoring devices

Where Pulsion Medical Systems is headquartered

Location

Headquarters

HQ city
Gothenburg
HQ country
Sweden
HQ region
Europe

Offices1 record

Markets served

Pulsion Medical Systems business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Pulsion Medical Systems product offering

Product offering

Core offering

Pulsion Medical Systems SE designs, develops, manufactures, and sells minimally invasive physiological monitoring systems used in intensive care units (ICUs) and patient rooms. The company focuses on medical technology solutions for intensive care and cardiovascular procedures, operating as a wholly-owned subsidiary of Getinge AB with MAQUET Medical Systems AG serving as the majority shareholder.

Product overview

Pulsion Medical Systems SE is a subsidiary of Getinge, operating as a medical technology company. The source data contains only investor relations information (shareholder meeting notices, financial reports from 2020-2024, articles of association, and administrative board composition) with no product or service listings.

Differentiator

Problem solved

Functional benefit

Companies that use Pulsion Medical Systems

Customer profile

Ideal customer profiles1 record

Pulsion Medical Systems technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Pulsion Medical Systems partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Getinge ABcoreStrategic or Co-development PartnerPulsion Medical Systems SE is a wholly-owned subsidiary of Getinge AB. MAQUET Medical Systems AG, a Getinge group company, is the majority shareholder. The company is undergoing delisting, with an extraordinary shareholders' meeting held on October 17, 2025 to approve the transfer of shares to Getinge.

Recent moves4 records

Expansion highlights2 records

Pulsion Medical Systems competitors and assessment

Company assessment

Market position

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Pulsion Medical Systems social profiles

Digital presence

Pulsion Medical Systems financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pulsion Medical Systems leadership team

Management profile

Number of profiles

Profiles3 records

Pulsion Medical Systems funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pulsion Medical Systems M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pulsion Medical Systems

What does Pulsion Medical Systems do?

Pulsion Medical Systems SE designs, develops, manufactures, and sells minimally invasive physiological monitoring systems used in intensive care units (ICUs) and patient rooms. The company focuses on medical technology solutions for intensive care and cardiovascular procedures, operating as a wholly-owned subsidiary of Getinge AB with MAQUET Medical Systems AG serving as the majority shareholder.

Is Pulsion Medical Systems a public or private company?

Pulsion Medical Systems is a public company. It is classified as corporate owned and is currently acquired.

When was Pulsion Medical Systems founded?

Pulsion Medical Systems was founded in 1904.

Where is Pulsion Medical Systems based?

Pulsion Medical Systems is headquartered in Gothenburg, Sweden, in the Europe region.

Does Pulsion Medical Systems have an API?

No public API is recorded for Pulsion Medical Systems.

What industry is Pulsion Medical Systems in?

Pulsion Medical Systems's product category is Patient Monitoring Systems. Its primary akta.pro industry code is HLAHAFAI, Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT), with a secondary code of HLAKANAH, Critical Care / ICU Pulmonology (Intensivist Services). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireThe hemodynamic monitoring systems market is projected to grow at a CAGR of 6.4%The global hemodynamic monitoring systems market is projected to grow from USD 857.8 million in 2018 to USD 1,167.4 million by 2023 at a CAGR of 6.4%, driven by technological advancements, rising cardiovascular disease prevalence, and increasing government focus on critical care infrastructure, though risks associated with invasive monitoring may restrain growth to some extent. The Asia Pacific region is expected to witness the highest growth during the forecast period, with Japan, India, China, Australia, and Singapore identified as key emerging markets. Key players in the market include Edwards Lifesciences Corporation, PULSION Medical Systems SE, LiDCO Group plc, Cheetah Medical, Deltex Medical Group Plc., ICU Medical, Osypka Medical GmbH, CareTaker Medical, CNSystems, NI Medical, and Uscom.PR NewswireResearch and Markets - Global Hemodynamic Monitoring Market 2016-2020 - Key Vendors are Edwards Lifesciences, ICU Medical, LiDCO & PULSION Medical Systems SEResearch and Markets has released its Global Hemodynamic Monitoring Market 2016-2020 report, projecting the market to grow at a compound annual growth rate of 6.44% during the forecast period. The report identifies Edwards Lifesciences, ICU Medical, LiDCO, and PULSION Medical Systems SE as the key vendors operating in this market. Key drivers for market growth include increasing demand for disease treatment and critical care, government funding programs such as the NIH's Vascular Interventions/Innovations and Therapeutic Advances Program, and the susceptibility of infants, women, and older populations to cardiac conditions.PR NewswireCytoSorbents Appoints Dr. Volker Humbert as Senior Manager of Clinical AffairsCytoSorbents Corporation announced the appointment of Dr. Volker Humbert as Senior Manager of Clinical Affairs to strengthen its medical expertise and support for its CytoSorb® blood filter. Dr. Humbert joins from PULSION Medical Systems, bringing extensive experience in critical care and regulatory affairs to help accelerate the adoption of the company's immunotherapy treatments. The role is intended to enhance communication and education among physicians regarding the use of CytoSorb® in treating conditions like sepsis and cardiac surgery complications.GlobeNewswireDGAP-AFR: PULSION Medical Systems SE: Announcement according to Articles 37v, 37w, 37x et seqq. of the WpHG [the German Securities Act] with the objective of Europe-wide distributionPulsion Medical Systems SE announced it will disclose its second-half interim report on November 11, 2014. The announcement was transmitted by DGAP, a service of EQS Group AG, and the company is solely responsible for the content.GlobeNewswireDGAP-Adhoc: Pulsion Medical Systems SE: General Meeting approves domination and profit and loss transfer agreementPulsion Medical Systems SE's extraordinary general meeting approved a domination and profit and loss transfer agreement with its controlling entity, MAQUET Medical Systems AG. The agreement provides a guaranteed dividend of 1.02 EUR per share (0.86 EUR net) and a cash compensation of 17.03 EUR per share, effective upon registration.GlobeNewswireDGAP-AFR: PULSION Medical Systems SE: Announcement according to Articles 37v, 37w, 37x et seqq. of the WpHG [the German Securities Act] with the objective of Europe-wide distributionPulsion Medical Systems SE announced it will disclose its Q2 financial report on August 12, 2014, in both German and English. The announcement was transmitted by DGAP, a service of EQS Group AG, and the company is solely responsible for the content.GlobeNewswireDGAP-Adhoc: Pulsion Medical Systems SE: Pulsion and MAQUET will enter into a domination and profit and loss transfer agreementPulsion Medical Systems SE and MAQUET Medical Systems AG agreed to a domination and profit and loss transfer agreement, with MAQUET offering to acquire minority shares at 17.03 EUR per share. The agreement also includes an annual recurring compensation of 1.02 EUR per share, and the extraordinary general meeting is scheduled for 14 August 2014.GlobeNewswireDGAP-Adhoc: Pulsion Medical Systems SE: DownlistingPulsion Medical Systems SE applied to the Frankfurt Stock Exchange to revoke its shares' admission to the Prime Standard and regulated market, following a May 15 downlisting decision. The revocation takes effect three months after publication for the Prime Standard and six months for the regulated market, after which shares trade only in the open market.GlobeNewswireDGAP-AFR: PULSION Medical Systems SE: Announcement according to Articles 37v, 37w, 37x et seqq. of the WpHG [the German Securities Act] with the objective of Europe-wide distributionPulsion Medical Systems SE announced it will disclose its annual financial report on March 25, 2014, in both German and English. The announcement was transmitted by DGAP, a company of EQS Group AG, and the report is available on the company's website.GlobeNewswireDGAP-PVR: Pulsion Medical Systems SE: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distributionOn February 24, 2014, Carl Bennet and related entities informed Pulsion Medical Systems SE that their voting rights exceeded multiple thresholds on February 19, 2014. The 78.16% voting rights (6,448,378 shares) were attributed to Carl Bennet AB and its controlled companies.